A Phase 2a, Randomized, Partially-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of 24 Weeks of Treatment With Multiple Doses of JNJ-56136379 as Monotherapy and in Combination With a Nucleos(t)ide Analog in Subjects With Chronic Hepatitis B Virus Infection (JADE)
21st May 2018 - ongoing
Status: Active
Specialism: Liver.
Team: Dr Steve Ryder.
People
| Photo | Name | Bio |
|---|---|---|
 |
Dr Steve Ryder |
Publications
| Title |
|---|
Grants
| Title | Amount |
|---|
